San Diego-based Genoptix has raised $17.3 million in a "series 1-D" round of venture capital. Genoptix provides laboratory services to hematologists and oncologists who are managing blood and bone marrow malignancies. Chicago Growth Partners joined existing investors Enterprise Partners, Alliance Technology Ventures, Tullis-Dickerson, U.S. Trust's Excelsior Venture Partners III, and Lotus Bioscience Investment Holdings in this round of financing.
- read this press release for more